Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Current status of COVID-19 treatment: An opinion review
Sveva Di Franco, Aniello Alfieri, Maria Beatrice Passavanti, Maria Caterina Pace, Marco Fiore, Department of Women, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples 80138, Italy
Stephen Petrou, Department of Emergency Medicine, Good Samaritan Hospital Medical Center, New York, NY 11795, United States
Giovanni Damiani, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan 20122, Italy
Giovanni Damiani, Clinical Dermatology, IRCCS Instituto Ortopedico Galeazzi, Milan 20122, Italy
Sebastiano Leone, Division of Infectious Diseases, “San Giuseppe Moscati” Hospital, Avellino 83100, Italy
Author contributions: Di Franco S and Alfieri A contributed equally to this study; Di Franco S and Alfieri A designed the study and performed the research; Passavanti MB, Pace MC and Leone S supervised the manuscript; Petrou S and Damiani G provided critical reviews; Di Franco S, Alfieri A, and Fiore M wrote the manuscript.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Marco Fiore, MD, Academic Fellow, Department of Women, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Piazza Miraglia 2, Naples 80138, Italy. marco.fiore@unicampania.it
Received: May 7, 2020
Peer-review started: May 7, 2020
First decision: July 25, 2020
Revised: August 7, 2020
Accepted: August 24, 2020
Article in press: August 24, 2020
Published online: September 25, 2020
Processing time: 140 Days and 4.9 Hours
Peer-review started: May 7, 2020
First decision: July 25, 2020
Revised: August 7, 2020
Accepted: August 24, 2020
Article in press: August 24, 2020
Published online: September 25, 2020
Processing time: 140 Days and 4.9 Hours
Core Tip
Core Tip: The pandemic spread of coronavirus disease 2019 (COVID-19) has led to the need to standardize a therapeutic approach in order to offer the same indications for all patients admitted to the hospital admissions for severe acute respiratory syndrome coronavirus 2 infection. However, no specific drug or drug regimen has been approved for treatment. This opinion review describes the recent literature on this topic and summarizes the treatment strategies currently in use for COVID-19 related complications.